Trademark: 86384407
Word
RETHINK ADHD ADULTS
Status
Dead
Status Code
606
Status Date
Monday, August 20, 2018
Serial Number
86384407
Mark Type
3000
Filing Date
Wednesday, September 3, 2014
Published for Opposition
Tuesday, May 19, 2015
Abandoned Date
Monday, August 20, 2018

Trademark Owner History
H. Lundbeck A-S - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment and prevention of brain and central nervous system diseases and disorders; sanitary preparations for medical purposes; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated from or acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated from or acting on the brain; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, depression, mood disorder, psychosis, stroke, anxiety, epilepsy, multiple sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, oncology, pain, alcoholism, alcohol dependence and addiction; medical diagnostic preparations, substances, reagents and agents
41 Education services, namely, providing continuing medical education courses; providing of training, namely, medical training and teaching; arranging and conducting educational seminars, conferences, symposiums, workshops and courses in the field of medicine; educational classes, courses, seminars and workshops and training services in the field of medical research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease; educational classes, courses, seminars and workshops and training services in the field of medical research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease provided electronically, on-line, the internet, and global communications networks; education services, namely, arranging and conducting of expert forums in the form of seminars, conferences, symposia, workshops and courses in the field of medicine; on-line medical training programs; providing non-downloadable on-line publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of medical research and development, science, clinical tests and trials, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease
42 Scientific and technological services, namely, research and design in the field of medicine; industrial analysis and research services in the field of pharmaceuticals; providing online non-downloadable software and an online searchable database in the field of research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention for the purpose of scientific research; providing a secured access website that gives medical experts the ability to upload, view, download, and share documents and images for the purposes of research and development in the field of clinical tests and trials, patient diagnostics, medicine, pharmaceuticals, medical disorders, diseases, treatment and prevention of disease; pharmaceutical research and development; scientific and technological services and research in the field of medical disorders, diseases and prevention of disease; scientific and technological services, namely, research in the field of the treatment and prevention of brain and central nervous system diseases, medical disorders and pharmaceuticals; medical research, conducting medical trials for others and testing of pharmaceuticals; conducting clinical research, trials and testing in the field of pharmaceuticals for others; medical diagnostic research and tests, including clinical trials for others; providing medical information in the field of pharmaceutical research and development, science, clinical tests and trials
44 Medical services in the field of psychiatry and psychology; medical advice in the field of medical and pharmaceutical preparations and substances; medical clinical services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; medical treatment services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; therapeutic treatment services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; therapeutic clinical services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; healthcare and medical services related to the treatment and prevention of central nervous system and brain disorders, diseases and pharmaceuticals; providing medical and medicinal information in the field of diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; medical information services; providing on-line medical data and analyses designed to provide patients and clients customized information, including medical dose, diagnosis, therapeutic issues and medical management
The color(s) blue and black is/are claimed as a feature of the mark.
"ADHD ADULTS"
The mark consists of the characters "RE" in blue and "THINK" in black on one line, and the characters "ADHD ADULTS" in blue on a second line. The characters are encircled by three blue rings and the tail of the "R" of "RE" is part of the middle ring. The background represents transparent areas only and is not a feature of the mark.

Trademark Events
Aug 20, 2018
Abandonment Notice Mailed - No Use Statement Filed
Aug 20, 2018
Abandonment - No Use Statement Filed
Dec 9, 2017
Notice Of Approval Of Extension Request E-Mailed
Dec 8, 2017
Extension 5 Granted
Dec 5, 2017
Extension 5 Filed
Dec 5, 2017
Teas Extension Received
Jun 22, 2017
Notice Of Approval Of Extension Request E-Mailed
Jun 20, 2017
Extension 4 Granted
Jun 20, 2017
Extension 4 Filed
Jun 20, 2017
Teas Extension Received
Jun 20, 2017
Teas Change Of Correspondence Received
Jan 5, 2017
Notice Of Approval Of Extension Request E-Mailed
Jan 3, 2017
Extension 3 Granted
Jan 3, 2017
Extension 3 Filed
Jan 3, 2017
Teas Extension Received
Jun 9, 2016
Notice Of Approval Of Extension Request E-Mailed
Jun 8, 2016
Extension 2 Granted
Jun 1, 2016
Extension 2 Filed
Jun 1, 2016
Teas Extension Received
Feb 3, 2016
Notice Of Approval Of Extension Request E-Mailed
Feb 2, 2016
Extension 1 Granted
Dec 15, 2015
Extension 1 Filed
Jan 28, 2016
Case Assigned To Intent To Use Paralegal
Dec 15, 2015
Teas Extension Received
Jul 14, 2015
Noa E-Mailed - Sou Required From Applicant
May 19, 2015
Official Gazette Publication Confirmation E-Mailed
May 19, 2015
Published For Opposition
Apr 29, 2015
Notification Of Notice Of Publication E-Mailed
Apr 13, 2015
Law Office Publication Review Completed
Apr 9, 2015
Approved For Pub - Principal Register
Apr 9, 2015
Examiner's Amendment Entered
Apr 9, 2015
Notification Of Examiners Amendment E-Mailed
Apr 9, 2015
Examiners Amendment E-Mailed
Apr 9, 2015
Examiners Amendment -Written
Apr 7, 2015
Teas/Email Correspondence Entered
Apr 7, 2015
Correspondence Received In Law Office
Mar 30, 2015
Assigned To Lie
Mar 24, 2015
Teas Response To Office Action Received
Oct 10, 2014
Notification Of Non-Final Action E-Mailed
Oct 10, 2014
Non-Final Action E-Mailed
Oct 10, 2014
Non-Final Action Written
Sep 30, 2014
Assigned To Examiner
Sep 16, 2014
Notice Of Design Search Code E-Mailed
Sep 15, 2014
New Application Office Supplied Data Entered In Tram
Sep 6, 2014
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24